Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Neoplasms 6Liver Neoplasms 5Neoplasms 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2Pancreatic Neoplasms 2Esophageal Squamous Cell Carcinoma 2Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Endometrial Neoplasms 1Deglutition Disorders 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1Anal Canal Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 685130-nm albumin-bound paclitaxel 199Fluorouracil 190Oxaliplatin 177Albumin-Bound Paclitaxel 154Capecitabine 137Leucovorin 133Irinotecan 114Radiotherapy 96Taxes 85pembrolizumab 81Cisplatin 73Erlotinib Hydrochloride 70Radiosurgery 69Nivolumab 56Drug Therapy 56Bevacizumab 54Magnetic Resonance Spectroscopy 51Cyclophosphamide 50folfirinox 45Specimen Handling 43Docetaxel 42Cetuximab 40Biopsy 39irinotecan sucrosofate 38S 1 (combination) 36Pancreaticoduodenectomy 35Blood Specimen Collection 34Surgical Procedures, Operative 31Paclitaxel 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Brachytherapy × Gastrointestinal × Clear all
NCT00079365 2013-12-04

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

National Cancer Institute (NCI)

Phase NA Unknown
Gastrointestinal

Pancreatic Neoplasms

NCT00002689 2013-07-18

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
48 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡